Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Oncolytics Biotech Inc. (T.ONC) had Return on Equity of 180.18% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-12.68M |
|
-- |
|
-- |
|
-- |
|
-12.74M |
|
-- |
|
-12.68M |
|
-12.68M |
|
-12.68M |
|
-12.68M |
|
-12.68M |
|
-12.68M |
|
-12.74M |
|
-12.72M |
|
112.29M |
|
112.29M |
|
-0.11 |
|
-0.11 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
11.20M |
|
-- |
|
-- |
|
-- |
|
18.24M |
|
-7.04M |
|
-7.04M |
|
-7.04M |
|
116.13M |
|
| Cash Flow Statement Financials | |
-10.01M |
|
-0.01M |
|
10.45M |
|
7.14M |
|
7.54M |
|
0.40M |
|
3.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.38 |
|
-- |
|
-- |
|
-0.07 |
|
-0.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
180.18% |
180.18% |
|
-113.26% |
|
193.05% |
|
-0.06 |
|
-0.09 |
|
-0.09 |
|